This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Multi-Center, Open label, Repeated Dose Range Fi...
Clinical trial

A Multi-Center, Open label, Repeated Dose Range Finding Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Efficacy of an Anti-IL-1? Monoclonal Antibody (ACZ885) Given Subcutaneously in Pediatric Subjects with Active Systemic

Read time: 1 mins
Last updated:14th Oct 2010
To evaluate the safety, tolerability and immunogenicity of sc administration of ACZ885 in pediatric subjects with active Systemic Juvenile Idiopathic Arthritis (SJIA).
Category Value
Study start date 2010-10-14

View full details